Improvement in bioavailability of transdermally applied flurbiprofen using tulsi (Ocimum sanctum) and turpentine oil

Colloids and Surfaces B: Biointerfaces

Volumn 65, Issue 2, 2008, Pages 300-307

  Charoo, Naseem Ahmad ^a   Shamsher, Areeg Anwer Ali ^a   Kohli, Kanchan ^a   Pillai, Krishna ^a   Rahman, Ziyaur ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Flurbiprofen; Histological studies; Pharmacokinetics; Terpenes; Transdermal delivery

Indexed keywords

BIOCHEMISTRY; CARBON NANOTUBES; ETHYLENE GLYCOL; GLYCOLS; PROPYLENE;

ABDOMINAL SKIN; ANTI-INFLAMMATORY; APPLIED (CO); FLURBIPROFEN (FP); ISO-PROPYL ALCOHOL (IPA); OCIMUM SANCTUM; PROPYLENE GLYCOL (PPG); SOLVENT MIXTURES; TRANSDERMAL DELIVERY; TRANSDERMAL PERMEATION; TURPENTINE OIL;

TURPENTINE;

2 PROPANOL; FLURBIPROFEN; HYDROXYPROPYLMETHYLCELLULOSE; IBUPROFEN; OCIMUM SANCTUM EXTRACT; PROPYLENE GLYCOL; SOLVENT; TULSI OIL; TURPENTINE OIL;

ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG FORMULATION; DRUG PENETRATION; DRUG STABILITY; ENCAPSULATION; INFLAMMATION; NONHUMAN; PAW EDEMA; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL AVAILABILITY; FLURBIPROFEN; PLANT OILS; RATS; TURPENTINE;

OCIMUM TENUIFLORUM; RATTUS;

EID: 46149105167     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2008.05.001     Document Type: Article

References (43)

1. Adams S., McCullough K., and Nicholson J. Arzneimittelforschung 25 (1975) 1786-1791
2. Brogden R.N., Heal R.C., Speight T.M., and Avery G.C. Drugs 18 (1979) 417-438
3. Nishizawa E. Throm. Res. 3 (1973) 577-588
4. Cardoe N., Risdall T.J., and Glass R.C. Curr. Med. Res. Opin. 3 Suppl. 4 (1975) 15
5. Teixeira A., Pocas L., and Serrao D. Br. J. Clin. Prac. 32 (1984) 222-227
6. Kitagawa H., Sakai T., Saito H., Mori M., and Tazoe R. Iyakuhin Kenkyu 13 (1993) 869-878
7. Kyuki K., Tsurumi K., Fujimura H., Masumoto S., and Hashimoto Y. Iyakuhin Kenkyu 15 (1984) 293-298
8. Potts R.O., Golden G.M., Francoeur M.L., Mak V.H., and Guy R.H. J. Controlled Release 15 (1991) 249-260
9. Chi S., Park E., and Kim H. Int. J. Pharm. 126 (1995) 267-274
10. Charoo N.A., Shamsher A.A., Kohli K., Pillai K.K., and Rehman Z. Pharm. Dev. Tech. 10 (2005) 343-351
11. Walker R., and Smith E. Adv. Drug Deliv. Rev. 18 (1996) 295-301
12. Berner J.H., Mazzenga G.C., Steffens R.J., and Ebert C.D. J. Pharm. Sci. 78 (1989) 314-318
13. Obata Y. Int. J. Pharm. 89 (1993) 191-198
14. Michniak B., Player M.R., Chapman J., and Sowell J.W. Int. J. Pharm. 91 (1993) 85-93
15. Aungst B.J., Blake J.A., and Hussain M.A. Pharm. Res. 7 (1990) 712-720
16. Puglia C., and Bonina F. Drug Deliv. 15 (2008) 107-112
17. Takahashi K., Tamagawa S., Kattagi T., Yoshitomi H., Kamada A., Rhytting J., Nishihata T., and Mizuro N. Chem. Pharm. Bull. 39 (1991) 154-158
18. Babu R.J., Dhanasekaran M., Vaithiyalingam S.R., Singh P.N., and Pandit J.K. Life Sci. 82 (2008) 273-278
19. Choi H.K., Amidon G.L., and Flynn G.L. J. Invest. Dermatol. 96 (1991) 822-826
20. Palma S.D., Maletto B., Lo Nostro P., Manzo R.H., Pistoresi-Palencia M.C., and Allemandi D.A. Drug Dev. Ind. Pharm. 32 (2006) 821-827
21. Williams A.C., and Barry B.W. Pharm. Res. 8 (1991) 17-24
22. M. Hashida, F. Yamashita, "Percutaneous Penetration Enhancers," in: E.W. Smith, H.I. Maibach (Eds.), CRC Press, Boca Raton, 1995, pp. 309-321.
23. Arellano A., Sontoya S., Martin C., and Ygartua P. Int. J. Pharm. 130 (1996) 141-145
24. Okabe H., Takayama K., and Nagai T. Chem. Pharm. Bull. 40 (1992) 1906-1910
25. Added to Food in the United States: A Food Additive Database, Food and Drug Administration, Rockville, MD, May 28, 1998.
26. Williams A.C., and Barry B.W. Int. J. Pharm. 74 (1991) 157-168
27. Cornwell P.A., Barry B.W., Bouwstra J.A., and Gooris G.S. Int. J. Pharm. 127 (1996) 9-26
28. Catz P., and Friend D. Int. J. Pharm. 58 (1990) 93-102
29. Hirvonen J., Sutinen R., Paronen P., and Urtti A. Int. J. Pharm. 99 (1993) 253-261
30. Buyuktimkin S., Buyuktimkin N., and Rytting J. Int. J. Pharm. 118 (1995) 113-119
31. Roy S., Roose E., and Sharma K. J. Pharm. Sci. 83 (1994) 126-130
32. United States Pharmacopoeial Convention Inc. 12601 Twinbrook Parkway, Rockville, MD 20852, 23 9(1995), p. 690.
33. Charoo N.A., Shamsher A.A., Kohli K., Pillai K.K., and Rehman Z. Chromatographia 62 (2005)
34. Moellguard B., and Hoelgaard A. Acta. Pharm. Succ. 20 (1983) 433-442
35. Hoelgaard A., and Moellguard B. J. Controlled Release 2 (1985) 111-120
36. Panchagnula R., Salve P.S., Thomas N.S., Jain A.K., and Ramarao P. Int. J. Pharm. 219 (2001) 95-105
37. Yamane Y., Williams A., and Barry B. J. Pharm. Pharmacol. 47 (1995) 978
38. Hadgraft J. Eur. J. Drug Metab. Pharmacokinet. 21 (1996) 165-173
39. Kim M.K., Zhao H., Lee C.H., and Kim D.D. Int. J. Pharm. 219 (2001) 51-59
40. El-Kattan A.F., Asbilks S., and Michniak B.B. Int. J. Pharm. 198 (2000) 179-189
41. Singh S. Pharm. Tech. 23 6 (1999) 68-168
42. Sasaki H., Nakamura J., Shibasaki J., Ishino Y., Miyasato K., and Ashizawa T. Chem. Pharm. Bull. 35 12 (1987) 4883-4890
43. Loganathan V., Manimaran S., Jaswanth V., Sulaiman A., Reddy S., SenthilUmar B., and Rajaseskaran A. Ind. J. Pharm. Sci. 63 3 (2001) 200-2004